ALLERTIN CAPSULE

Страна: Канада

Език: английски

Източник: Health Canada

Активна съставка:

LORATADINE

Предлага се от:

APOTEX INC

АТС код:

R06AX13

INN (Международно Name):

LORATADINE

дозиране:

10MG

Лекарствена форма:

CAPSULE

Композиция:

LORATADINE 10MG

Начин на приложение:

ORAL

Броя в опаковка:

12/24

Вид предписание :

OTC

Терапевтична област:

SECOND GENERATION ANTIHISTAMINES

Каталог на резюме:

Active ingredient group (AIG) number: 0120416001; AHFS:

Статус Оторизация:

APPROVED

Дата Оторизация:

2012-08-02

Данни за продукта

Page 2 of 20
PRODUCT MONOGRAPH
ALLERTIN
LORATADINE CAPSULES, 10 MG
HISTAMINE H
1 RECEPTOR ANTAGONIST
APOTEX INC.
DATE OF REVISION:
150 SIGNET DRIVE
SEPTEMBER 25, 2019
TORONTO, ONTARIO
CANADA M9L 1T9
CONTROL #: 231181
Page 3 of 20
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.......................................................................
4
SUMMARY PRODUCT INFORMATION
.............................................................................................
4
INDICATIONS AND CLINICAL USE
...................................................................................................
4
CONTRAINDICATIONS
........................................................................................................................
4
WARNINGS AND PRECAUTIONS
.......................................................................................................
4
ADVERSE REACTIONS
.........................................................................................................................
5
DRUG INTERACTIONS
.........................................................................................................................
6
DOSAGE AND ADMINISTRATION
.....................................................................................................
7
OVERDOSAGE
.......................................................................................................................................
7
ACTION AND CLINICAL
PHARMACOLOGY....................................................................................
8
STORAGE AND STABILITY
.................................................................................................................
9
SPECIAL HANDLING INSTRUCTIONS
..............................................................................................
9
DOSAGE FORMS, COMPOSITION AND PACKAGING
.................................................................... 9
PART II: SCIENTIFIC INFORMATION
.....................................................................